Advertisement

Does Serum Magnesium Concentration Prevent Mitral Annular Calcification in Hemodialysis Patients?

  • J. Tzanakis
  • N. Kallivretakis
  • A. Pras
  • K. Virvidakis
  • D. Mayopoulou-Symvoulidou
  • T. Mountokalakis
Chapter

Abstract

Cardiac valve calcifications are common in patients on chronic hemodialysis. Magnesium (Mg) status is one of several factors implicated in the pathogenesis of this complication (Meema et al., 1987; Rostand et al., 1988). The present study was scheduled to study the relationship between mitral annular calcification and various biochemical, hormonal, and demographic parameters, namely serum Mg, calcium (Ca), phosphate (P), CaXP product, parathyroid (PTH) levels, age and duration of dialysis therapy, in patients on chronic hemodialysis.

Keywords

Hemodialysis Patient Demographic Parameter Serum Magnesium Chronic Hemodialysis Arterial Calcification 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Meema, H.E., Oreopoulos, D.G., Rapaport A. (1987) Serum magnesium levels and arterial calcification in end-stage renal disease. Kidney Int. 32, 388–394.CrossRefGoogle Scholar
  2. Rostand, S.G., Sanders, C., Kirk, K.A., Rutsky E.A., Fraser R.G. (1988) Myocardial calcification and cardiac dysfunction in chronic renal failure. Am. J. Med. 85, 651–657.CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • J. Tzanakis
    • 1
  • N. Kallivretakis
    • 1
  • A. Pras
    • 1
  • K. Virvidakis
    • 1
  • D. Mayopoulou-Symvoulidou
    • 1
  • T. Mountokalakis
    • 1
  1. 1.Departments of Nephrology and Cardiology, General Hospital of Chania, Crete and 3rd Department of Medicine, Medical SchoolUniversity of Athens, Sotiria General HospitalAthensGreece

Personalised recommendations